Chronicle Journal: Finance

Temple spinoff Express Cells secures first patent for gene-editing technology

The company raised $800,000 in funding in 2019.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.